Enquiry/Quote
Tirbanibulin bulk supplier for pharma manufacturers

Tirbanibulin Suppliers & Bulk Manufacturers

Available Forms: Ointment

Available Strengths: 1%

Reference Brands: Klisyri (USA)

Category: Derma Drugs

Tirbanibulin is a microtubule inhibitor that binds to tubulin and inhibits tubulin polymerization. It also inhibits Src‑kinase signalling pathways. By doing so, it arrests cell division in rapidly dividing skin cells affected by sun damage, leading to their death. It is used for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis on the face or scalp, helping clear precancerous skin lesions and reduce the risk of progression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Tirbanibulin is used to treat actinic keratosis, a precancerous skin condition caused by sun damage. It works by inhibiting tubulin polymerization and Src kinase signaling, which disrupts the growth of abnormal skin cells.

Tirbanibulin is made from the active pharmaceutical ingredient tirbanibulin, a synthetic molecule that targets cellular microtubules and signaling pathways involved in abnormal cell proliferation.

The trade name is Klisyri.

Klisyri is manufactured by Almirall, S.A.

The generic name is tirbanibulin.

The primary brand name is Klisyri.

It is manufactured in approved pharmaceutical facilities in Europe and other regions depending on regulatory approvals.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.